{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52649"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52649","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"THE ROLE OF ARYL HYDROCARBON RECEPTOR IN BREAST CANCER","abstract":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Gonzalez-Pons, Romina"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Bernard, Jamie J","Upham, Brad","Dorrance, Anne","Horibata, Sachi"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:09Z","subjects":["Toxicology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52649","local:GonzalezPons_grad.msu_0128D_21616"],"render_values":[{"text":"etd:52649","href":null,"code":true},{"text":"local:GonzalezPons_grad.msu_0128D_21616","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/y5hs-7p04","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/y5hs-7p04","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52649","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Bernard, Jamie J","Upham, Brad","Dorrance, Anne","Horibata, Sachi"]},{"key":"dc:creator","label":"Author","values":["Gonzalez-Pons, Romina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Toxicology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52649","local:GonzalezPons_grad.msu_0128D_21616","https://doi.org/doi:10.25335/y5hs-7p04"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2025","Why do breast cancer cases continue to rise despite significant advancements in treatment? This underscores the urgent need to understand the factors driving cancer promotion and to uncover the underlying biological mechanisms. What makes breast cells particularly susceptible to malignancy? Identifying these vulnerability factors is crucial for developing targeted prevention strategies to intervene at the earliest stages, preventing cancer before it takes hold. Triple-negative breast cancer (TNBC) is an aggressive subtype that lacks effective preventive therapies due to the absence of estrogen, progesterone, and human epidermal growth factor 2 receptors. Conversely, although estrogen receptor-positive breast cancer (BC) is more responsive to treatment, many patients eventually develop resistance to endocrine therapies. While the exact causes of BC remain complex, one factor, obesity, has seen a parallel rise in incidence and contributes to all stages of breast carcinogenesis. Despite decades of observation, the mechanistic link between excess adiposity and breast tumorigenesis is poorly understood. My research aims to address this gap by investigating a novel, hormone receptor-independent pathway driven by the aryl hydrocarbon receptor (AhR). I demonstrated that high AhR expression is associated with worse overall survival in breast cancer, and previous studies have implicated AhR in the development and progression of the disease. Using an innovative in vitro model, I have shown that non-tumorigenic breast epithelial cells undergo malignant transformation when exposed to adipose tissue-derived kynurenine (Kyn). Elevated Kyn levels are observed in patients with BC and subjects with obesity. I further showed that adipocytes metabolize tryptophan into Kyn, now recognized as an oncometabolite. Additionally, exposure to environmental toxicants such as benzo[a]pyrene increases circulating Kyn in obese preclinical models. Importantly, I provided evidence that inhibiting AhR, either through genetic knockdown or pharmacological inhibition, prevents transformation of mammary cells. This thesis has broad implications for oncology, as Kyn is implicated in multiple cancer types. Understanding these mechanisms could open new avenues for targeted prevention and therapeutic strategies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (140 p.) : ill."]},{"key":"dc:title","label":"Title","values":["THE ROLE OF ARYL HYDROCARBON RECEPTOR IN BREAST CANCER"]}]}],"canonical_facts":{"dc:contributor":["Bernard, Jamie J","Upham, Brad","Dorrance, Anne","Horibata, Sachi"],"dc:creator":["Gonzalez-Pons, Romina"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology - Doctor of Philosophy, 2025","Why do breast cancer cases continue to rise despite significant advancements in treatment? This underscores the urgent need to understand the factors driving cancer promotion and to uncover the underlying biological mechanisms. What makes breast cells particularly susceptible to malignancy? Identifying these vulnerability factors is crucial for developing targeted prevention strategies to intervene at the earliest stages, preventing cancer before it takes hold. Triple-negative breast cancer (TNBC) is an aggressive subtype that lacks effective preventive therapies due to the absence of estrogen, progesterone, and human epidermal growth factor 2 receptors. Conversely, although estrogen receptor-positive breast cancer (BC) is more responsive to treatment, many patients eventually develop resistance to endocrine therapies. While the exact causes of BC remain complex, one factor, obesity, has seen a parallel rise in incidence and contributes to all stages of breast carcinogenesis. Despite decades of observation, the mechanistic link between excess adiposity and breast tumorigenesis is poorly understood. My research aims to address this gap by investigating a novel, hormone receptor-independent pathway driven by the aryl hydrocarbon receptor (AhR). I demonstrated that high AhR expression is associated with worse overall survival in breast cancer, and previous studies have implicated AhR in the development and progression of the disease. Using an innovative in vitro model, I have shown that non-tumorigenic breast epithelial cells undergo malignant transformation when exposed to adipose tissue-derived kynurenine (Kyn). Elevated Kyn levels are observed in patients with BC and subjects with obesity. I further showed that adipocytes metabolize tryptophan into Kyn, now recognized as an oncometabolite. Additionally, exposure to environmental toxicants such as benzo[a]pyrene increases circulating Kyn in obese preclinical models. Importantly, I provided evidence that inhibiting AhR, either through genetic knockdown or pharmacological inhibition, prevents transformation of mammary cells. This thesis has broad implications for oncology, as Kyn is implicated in multiple cancer types. Understanding these mechanisms could open new avenues for targeted prevention and therapeutic strategies.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (140 p.) : ill."],"dc:identifier":["etd:52649","local:GonzalezPons_grad.msu_0128D_21616","https://doi.org/doi:10.25335/y5hs-7p04"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Toxicology"],"dc:title":["THE ROLE OF ARYL HYDROCARBON RECEPTOR IN BREAST CANCER"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:09Z"}